Torrent Pharmaceuticals Board Approves ₹12,500 Crore Non-Convertible Debentures Issuance 

Mumbai, 5 January 2026: Torrent Pharmaceuticals Ltd (CIN: L24239GJ1972PLC002126) announced that it is planning to raise money by way of non-convertible debentures (NCDs) to the maximum amount of 12,500 crore. 

Board Clears NCD Issuance of up to 12,500 Crore 

The approval is for the issuance of the secured, rated, listed and redeemable NCDs. The disclosure is under the listing regulations as part of a corporate announcement. The complete utilisation of the limit has no particular time schedule. 

The issuance of NCDs is suggested on a privately placed basis. This is normally issued by identified investors and listed on recognised stock exchanges, subject to the same rules. The permission is a facilitating measure to come into the debt market with the given limit. 

Issue Route To Tranche-Based Fundraising 

The company is raising funds in one or more tranches within the total limit. The specifications, like tenure, rating specifications and final size per tranche, are fixed closer to the date of issuance. It is subject to the market conditions and approvals associated with every tranche. 

There is no breakdown of the distribution of the funds to be spent on particular uses. Any future information will be disclosed in the form of further regulatory filings. 

Net Profit Rose to ₹1,911 Crore In FY25 

Torrent Pharmaceuticals (PAT) stood at 191 crore post tax (PAT) in FY25 as compared to 1656 crore in FY24. The FY25 revenue was 11,516 crore compared to 10,728 crore in FY24. 

JB Chemicals Buyout Remains in View 

The firm is still in the JB Chemicals buyout stages. The proposed acquisition plan has already been cleared of competition. On the regulatory side, the transaction has also made headway with the minimum tender offer associated with the open offer requirement being cleared by the SEBI. 

Stock Performance 

Torrent Pharmaceuticals ltd share price were at 3:50 pm IST at Rs. 3,872.90. At around the same time, the NSE quote was Rs.3,872.90 at 3:50 pm IST and overall NSE and BSE volume was 66,145 shares. The market cap of the company was around Rs.1.31 lakh crore. 

Torrent Pharmaceuticals Business Snapshot. 

Torrent Pharmaceuticals is a pharmaceutical company that is present in brand formulations and healthcare divisions. The company trades in the stock markets of India and it posts its corporate activities and fundraising news on a regular basis by submitting exchange filings. 

Reference

• https://nsearchives.nseindia.com/corporate/TORNTPHARM_05012026172114_SECreditRating05012026.pdf
• https://nsearchives.nseindia.com/corporate/TORNTPHARM_05012026111036_se050126.pdf
• https://nsearchives.nseindia.com/corporate/TORNTPHARM_05012026110829_se050126.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.  

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.  

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations